As of November 7, 2026, CervoMed Inc. is a publicly traded company (Nasdaq: CRVO). The largest holder reporting an active stake on Schedule 13D is Joshua S. Boger, a director and 10% owner, at 20%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Armistice Capital (9.53%), RA Capital (8.6%), Woodline Partners LP (5.1%) (Schedule 13D/A, June 15, 2026).
Is this your company?
About to sign with, pay or invest in CervoMed Inc.? See the free Snapshot first.
Free to see. No signup.
Is CervoMed Inc. a real, registered company?
- CervoMed Inc. files with the SEC under CIK 1053691 (its SEC filings).
- Its shares are listed under the ticker CRVO on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Boston, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CervoMed Inc. in our court records and SEC 8-K records (as of 2026-11-07).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Woodline Partners LP (filed 2026-08-14).
Who are CervoMed Inc.'s owners and officers?
CervoMed Inc.: incorporated in Delaware; business address in Boston, Massachusetts; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-14 | Woodline Partners LP | 5.1% |
| Schedule 13G, 2026-08-14 | Armistice Capital, LLC | 9.53% |
| Schedule 13G/A, 2026-08-14 | Cvi Investments, Inc. | 0% |
| Schedule 13G/A, 2026-08-14 | Ra Capital Management, L.P. | 8.6% |
| Schedule 13G/A, 2026-07-08 | Morgan Stanley | 0.1% |
| Schedule 13G, 2026-06-26 | Cvi Investments, Inc. | 5.5% |
| Schedule 13D/A, 2026-06-15 | Boger Joshua S | 20% |
| Schedule 13G/A, 2026-05-11 | Morgan Stanley | 8% |
| Schedule 13G/A, 2026-04-07 | Awm Investment Company, Inc. | 4.2% |
| Schedule 13G, 2026-02-11 | Morgan Stanley | 5.1% |
| Schedule 13G/A, 2025-08-20 | Ra Capital Management, L.P. | 9.9% |
| Schedule 13G/A, 2025-08-14 | Ra Capital Management, L.P. | 0% |
Questions about who owns CervoMed Inc.
Who owns CervoMed Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of CervoMed Inc.: Boger Joshua S (20%, Schedule 13D/A, filed 2026-06-15), Armistice Capital, LLC (9.53%, Schedule 13G, filed 2026-08-14), Ra Capital Management, L.P. (8.6%, Schedule 13G/A, filed 2026-08-14) and Woodline Partners LP (5.1%, Schedule 13G, filed 2026-08-14).
Who are the largest shareholders of CervoMed Inc.?
By the share each holder's latest filing reports, the largest holders of CervoMed Inc. on this page are Boger Joshua S (20%), Armistice Capital, LLC (9.53%) and Ra Capital Management, L.P. (8.6%).
When did Boger Joshua S buy into CervoMed Inc.?
The filings give report dates, not purchase dates. The earliest filing from Boger Joshua S on this page is the Schedule 13D/A, filed 2026-06-15, reporting 20%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on CervoMed Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on CervoMed Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CervoMed Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own CervoMed Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 2,012,682 shares (13.3% of shares outstanding), 216,817 held directly and 1,795,865 indirectly (Form 4, 2026-06-15).
- , a director and 10% owner: 1,496,578 shares (9.9% of shares outstanding), 1,484,078 held directly and 12,500 indirectly (Form 4, 2025-11-19).
- , the chief executive and president: 1,496,578 shares (9.9% of shares outstanding), 1,484,078 held directly and 12,500 indirectly (Form 4, 2025-11-19).
- , the chief commercial and business: 15,000 shares (0.10% of shares outstanding) (Form 4, 2025-11-19).
- , the chief financial officer and general counsel: 12,500 shares (0.08% of shares outstanding) (Form 4, 2025-11-19).
Shares outstanding: 15,128,540 as of 2026-11-04, from the company's latest SEC cover page.
How much has CervoMed Inc. raised?
No fundraising or offering filing from CervoMed Inc. is on file with us.
Keep reading
More on CervoMed Inc. and the records around it.
CervoMed Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Woodline Partners LP also filed stake reports on 19 other companies: Biohaven Ltd. (Aug 2026), Black Rock Coffee Bar, Inc. (Aug 2026), CalciMedica, Inc. (Aug 2026)
- AWM Investment Company, Inc. also filed stake reports on 32 other companies: 908 Devices Inc. (Aug 2026), Brazil Potash Corp. (Aug 2026), EVERSPIN TECHNOLOGIES INC. (Aug 2026)
- CVI Investments, Inc. also filed stake reports on 48 other companies: Pine Tree Acquisition Corp. (Oct 2026), Sunshine Biopharma Inc. (Oct 2026), Outlook Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/cervomed